[go: up one dir, main page]

ATE329031T1 - Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen - Google Patents

Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen

Info

Publication number
ATE329031T1
ATE329031T1 AT96938863T AT96938863T ATE329031T1 AT E329031 T1 ATE329031 T1 AT E329031T1 AT 96938863 T AT96938863 T AT 96938863T AT 96938863 T AT96938863 T AT 96938863T AT E329031 T1 ATE329031 T1 AT E329031T1
Authority
AT
Austria
Prior art keywords
treatment
lawsonia intracellularis
therapeutic compositions
intracellularis infections
prophylaxis
Prior art date
Application number
AT96938863T
Other languages
English (en)
Inventor
Michael Panaccio
Detlef Hasse
Original Assignee
Agriculture Victoria Serv Pty
Australian Pork Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN6910A external-priority patent/AUPN691095A0/en
Priority claimed from AUPN6911A external-priority patent/AUPN691195A0/en
Application filed by Agriculture Victoria Serv Pty, Australian Pork Ltd filed Critical Agriculture Victoria Serv Pty
Application granted granted Critical
Publication of ATE329031T1 publication Critical patent/ATE329031T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96938863T 1995-11-30 1996-11-29 Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen ATE329031T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN6910A AUPN691095A0 (en) 1995-11-30 1995-11-30 Therapeutic and diagnostic compositions - A
AUPN6911A AUPN691195A0 (en) 1995-11-30 1995-11-30 Therapeutic and diagnostic compositions - B

Publications (1)

Publication Number Publication Date
ATE329031T1 true ATE329031T1 (de) 2006-06-15

Family

ID=25645072

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96938863T ATE329031T1 (de) 1995-11-30 1996-11-29 Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen

Country Status (11)

Country Link
US (1) US7022328B1 (de)
EP (1) EP0871735B1 (de)
JP (1) JP2000502054A (de)
CN (1) CN1145697C (de)
AT (1) ATE329031T1 (de)
AU (1) AU718333B2 (de)
BR (1) BR9611623A (de)
CA (1) CA2236574A1 (de)
DE (1) DE69636228D1 (de)
NZ (1) NZ322398A (de)
WO (1) WO1997020050A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2345061A (en) * 1998-12-21 2000-06-28 Secr Defence Protein and nucleic acid sequences of groES and groEL from B.pseudomallei and their use as a vaccine
BR0011290A (pt) * 1999-05-13 2002-05-21 Agriculture Victoria Serv Pty Gene derivado de lawsonia e polipeptìdeos, peptìdeos e proteìnas de omph relacionados e seus usos
US7052697B1 (en) * 1999-05-13 2006-05-30 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
EP1181315A4 (de) * 1999-05-13 2002-08-14 Pfizer Prod Inc VON LAWSONIA ABSTAMMENDE GENE UND VERWANDTE F1gE POLYPEPTIDE, PEPTIDE UND PROTEINE UND IHRE VERWENDUNGEN
US7029683B1 (en) 1999-05-13 2006-04-18 Pfizer Products, Inc. Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
BR0011292A (pt) * 1999-05-13 2002-02-26 Pfizer Prod Inc Gene derivado de lawsonia e proteìnas, peptìdeos e polipeptìdeos sodc relacionados e seus usos
WO2000069906A1 (en) * 1999-05-13 2000-11-23 Pfizer Products Inc Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
US6605696B1 (en) 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
EP1094070A3 (de) * 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis Proteine sowie Methoden und Materialien die diese verwenden
GB0021757D0 (en) * 2000-09-04 2000-10-18 Colaco Camilo Vaccine against microbial pathogens
JP2004529854A (ja) * 2000-09-29 2004-09-30 アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
WO2002038594A1 (en) * 2000-11-10 2002-05-16 Agriculture Victoria Services Pty. Ltd. Novel therapeutic compositions for treating infection by lawsonia spp
DK1586646T3 (da) 2000-12-20 2011-06-27 Intervet Int Bv Lawsonia intracellularis-vaccine
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
AR053372A1 (es) * 2005-04-28 2007-05-02 Boehringer Ingelheim Int Proteinas inmunologicas de lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
WO2008073464A2 (en) 2006-12-11 2008-06-19 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP2200643B1 (de) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. Ein lawsonia intracellularis lebendimpfstoff verabreicht in kombination mit einem antibiotikum zur behandlung von lawsonia intracellularis infektionen in schweine
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
RU2523561C2 (ru) * 2008-04-18 2014-07-20 Интервет Интернэшнл Б.В. Вакцина для защиты от lawsonia intracellularis
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
WO2010010055A1 (en) * 2008-07-22 2010-01-28 Intervet International B.V. Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
WO2015082465A1 (en) * 2013-12-03 2015-06-11 Intervet International B.V. Swine vaccine against prrs and lawsonia intracellularis
JP6605469B2 (ja) 2013-12-03 2019-11-13 インターベット インターナショナル ベー． フェー． ブタサーコウイルス２型に対するワクチン
ES2786194T3 (es) 2013-12-03 2020-10-09 Intervet Int Bv Vacuna contra Lawsonia intracellularis y el circovirus porcino de tipo 2
JP2018504423A (ja) * 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
JP2018504424A (ja) * 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
EA202091994A1 (ru) * 2018-02-28 2020-12-25 Бёрингер Ингельхайм Ветмедика Гмбх Способ снижения скатола и/или индола у животных
WO2023073640A1 (en) 2021-11-01 2023-05-04 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610059A (en) 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5714375A (en) * 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
US6379677B1 (en) * 2000-02-25 2002-04-30 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Streptococcus iniae vaccine

Also Published As

Publication number Publication date
NZ322398A (en) 2000-02-28
AU7614196A (en) 1997-06-19
CA2236574A1 (en) 1997-06-05
CN1203630A (zh) 1998-12-30
DE69636228D1 (de) 2006-07-20
WO1997020050A1 (en) 1997-06-05
EP0871735A1 (de) 1998-10-21
AU718333B2 (en) 2000-04-13
CN1145697C (zh) 2004-04-14
BR9611623A (pt) 1999-12-28
JP2000502054A (ja) 2000-02-22
US7022328B1 (en) 2006-04-04
EP0871735A4 (de) 2001-12-05
EP0871735B1 (de) 2006-06-07

Similar Documents

Publication Publication Date Title
ATE329031T1 (de) Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen
EP0703911A1 (de) Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit
ATE218880T1 (de) Verfahren zur behandlung von gram-negativen bakterien infektion durch verabreichung von bakterientötendem/durchlässigkeiterhöhendem (bpi) proteinprodukt und antibiotikum
NO20030316L (no) Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker
ATE510562T1 (de) Anti-ailim antikörper zur behandlung von crohn's
DE60325945D1 (de) Zusammensetzungen und verfahren für die behandlung von mikroorganismen-infektionen
ATE310391T1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen
YU46097A (sh) Nova klasa estara i njihove farmaceutske smeše
ATE345115T1 (de) Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten
BR0015698A (pt) Composições e métodos para tratamento de doenças alérgicas
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
ATE289821T1 (de) Verfahren zur behandlung einer diarrhöischen krankheit und zur eliminierung besonderer bakterieller populationen im dickdarm
BR0200571A (pt) Produtos de legumes
ATE408618T1 (de) Synthetische peptidkonstrukte zur erkennung und behandlung von parodontose hervorgerufen durch porphyromonas gingivalis
DE69012329D1 (de) Bakterielle mittel zur verwendung bei geflügel.
SE8903625L (sv) Antibacterial composition
EA200001029A1 (ru) Производные гигромицина
EP0966196A4 (de) Zusammensetzung zur organ-kryokonservierung und behandlung von viralen und bakteriellen infektionen
HUP0003845A2 (hu) Antimikrobiális 8a-azalidok alkalmazása
DE69829995D1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
ATE308895T1 (de) Behandlung von infektionen in tieren
DE69918826D1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
ATE212229T1 (de) Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden
DE60041266D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE69619542D1 (de) Bismut enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties